PROCEPT BioRobotics Corporation (BMV:PRCT)

Market Cap	28.05B -65.1%
Revenue (ttm)	5.50B +50.1%
Net Income	-1.55B
EPS	-28.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	700
Average Volume	1,746
Open	543.54
Previous Close	536.00
Day's Range	543.54 - 543.54
52-Week Range	536.00 - 1,217.38
Beta	n/a
RSI	n/a
Earnings Date	Feb 24, 2026

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign p...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2007
• Employees: 756
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PRCT

Financial Performance

In 2024, PROCEPT BioRobotics's revenue was $224.50 million, an increase of 64.84% compared to the previous year's $136.19 million. Losses were -$91.41 million, -13.68% less than in 2023.

Financial numbers in USD